Qingdao Haier Biomedical Co (SHSE:688139) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Change In Receivables?

Qingdao Haier Biomedical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Qingdao Haier Biomedical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Qingdao Haier Biomedical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥52 Mil. It means Qingdao Haier Biomedical Co's Accounts Receivable declined by ¥52 Mil from Dec. 2022 to Dec. 2023 .

Qingdao Haier Biomedical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥335 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Qingdao Haier Biomedical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 44.46.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Qingdao Haier Biomedical Co's liquidation value for the three months ended in Mar. 2024 was ¥1,247 Mil.

Qingdao Haier Biomedical Co Change In Receivables Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Change In Receivables Chart

Qingdao Haier Biomedical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-56.43

39.62

67.46

-37.56

52.35

Qingdao Haier Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Qingdao Haier Biomedical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Qingdao Haier Biomedical Co (SHSE:688139) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Qingdao Haier Biomedical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	334.708	/	686.909	*	91
=	44.46

2. In Ben Graham's calculation of liquidation value, Qingdao Haier Biomedical Co's accounts receivable are only considered to be worth 75% of book value:

Qingdao Haier Biomedical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2001.189	-	1130.338	+	0.75 * 334.708	+	0.5 * 250.845
=	1,247

Qingdao Haier Biomedical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Haier Road, Branding Building, Qingdao, CHN, 266101

Website

http://www.haiermedical.com

Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.

Executives

Zhang Jiang Tao	Core technical personnel
Liu Ji Yuan	Core technical personnel
Teng Pei Kun	Core technical personnel
Wang Guang Sheng	senior management
Gong Yi	Director
Huang Yan Li	senior management
Chen Hai Tao	Senior management, core technical personnel
Liu Zhan Jie	Directors, senior managers, core technical personn
Mo Rui Juan	senior management
Wang Wen Fu	Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines